Analysts expect Outlook Therapeutics, Inc. to report revenue of 2.82 M for Q4 26, against a range of 2.56 M to 3.07 M. The most recent reported quarter, Q3 26, came in at 9,000.00, a 99.0% miss against the 938,148.40 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 1.50 M | -1.21 M | 128,000.00 | 9,000.00 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 709,424.87 | 1.57 M | 3.28 M | 4.82 M | 1.03 M | 3.07 M | 5.84 M | 10.43 M | 11.78 M | 12.91 M | 36.57 M | 39.21 M | 48.92 M | |||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 621,673.53 | 1.34 M | 2.74 M | 4.18 M | 850,348.97 | 2.56 M | 5.44 M | 8.79 M | 10.86 M | 11.23 M | 34.39 M | 36.78 M | 44.76 M | |||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 665,549.20 | 1.45 M | 3.01 M | 4.50 M | 938,148.40 | 2.82 M | 5.64 M | 9.61 M | 11.32 M | 12.07 M | 35.48 M | 38.00 M | 46.84 M |
Analysts expect Outlook Therapeutics, Inc. to report earnings per share of -0.07 for Q4 26, against a range of -0.07 to -0.07. The most recent reported quarter, Q3 26, came in at -0.09, a 12.5% miss against the -0.08 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.83 | -0.88 | -0.89 | -0.40 | -0.44 | -0.22 | -0.16 | -0.09 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -1.01 | -0.77 | -0.67 | -0.48 | -0.31 | -0.22 | -0.13 | -0.07 | -0.07 | -0.06 | -0.05 | -0.05 | -0.02 | 0.04 | 0.13 | 0.10 | |||||||||
| Low Estimate | -1.15 | -0.91 | -0.75 | -0.54 | -0.37 | -0.26 | -0.13 | -0.09 | -0.07 | -0.06 | -0.05 | -0.05 | -0.02 | 0.04 | 0.11 | 0.10 | |||||||||
| Consensus Estimate | -1.08 | -0.84 | -0.71 | -0.51 | -0.34 | -0.24 | -0.13 | -0.08 | -0.07 | -0.06 | -0.05 | -0.05 | -0.02 | 0.04 | 0.12 | 0.10 |
Pull Wall Street consensus for Outlook Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=OTLK&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "OTLK", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=OTLK&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();